_gif.gif)
Swiss biotechnology and nutritional food company Oberland Biotech GmbH has completed a CHF 2.5 million seed funding round to accelerate its international market presence and product development pipelines.
The capital injection, which was secured through a convertible instrument, was supported by Kataria Holdings Ltd under the supervision of its lead investment team.
The financing marks a major milestone for the early-stage Swiss business as it seeks to scale its operations across the international biotechnology and functional nutrition sectors.
Capital Allocation
Oberland Biotech plans to allocate the newly secured funds across several core operational areas to support its next phase of commercial growth. Key investment priorities include:
Product Development: Enhancing the company's research pipeline to develop new nutritional supplements and functional food solutions.
International Expansion: Scaling commercial trade, sales, and export activities beyond its domestic European market.
Recruitment: Hiring specialised talent across scientific, operational, and commercial departments.
Marketing and Sales: Expanding regional marketing campaigns and building wholesale distribution networks to drive volume growth.
International Footprint
The company's long-term commercial strategy prioritises establishing a robust physical and digital presence in high-volume international markets.
Specifically, Oberland Biotech intends to focus its near-term expansion efforts on the United States and Asian markets. By targeting these regions, the firm aims to integrate its products into established biotechnology and consumer health ecosystems.
Phillip Josef Jancer, Chief Executive Officer and Founder of Oberland Biotech, stated that the funding provides the necessary financial resources to advance the company's product pipeline and scale its international footprint.
He also acknowledged the role of Kataria Holdings Ltd, specifically Chief Operating Officer Kumar Kataria, in supporting the transaction and guiding the business through the funding process.
Trade Operations
Oberland Biotech operates as a vertically integrated biotechnology and food-focused company. The business specialises in the trade, sale, and export of nutritional supplements and dietary products globally.
Through strategic collaborations, the establishment of international subsidiaries, and participation in targeted food-tech projects, the firm maintains a flexible operational structure designed to support long-term volume growth in the global bioeconomy.
